Treatment of malignant acanthosis nigricans with cyproheptadine.
D000052:Acanthosis Nigricans / Q000188:drug therapy* / Q000209:etiology; D000230:Adenocarcinoma / Q000150:complications; D003533:Cyproheptadine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000150:complications; D013274:Stomach Neoplasms / Q000150:complications
D003533:Cyproheptadine